Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Angle | DWV | 30. avr 2024 | 0.15 | -1.91 |
Avricore Health Inc. | 8VP1 | 30. avr 2024 | 0.08 | -4.02 |
Biomaxima SA | 944 | 30. avr 2024 | 3.07 | +0.33 |
Biosynex | 0DL | 30. avr 2024 | 4.11 | +1.73 |
Clearbridge Health Limited | 5C6 | 30. avr 2024 | 0.01 | 0.00 |
Clinica Baviera | D9Z | 30. avr 2024 | 28.00 | 0.00 |
EKF Diagnostics Holdings plc | LYF | 30. avr 2024 | 0.32 | +2.53 |
Eurobio Scientific | E8TN | 30. avr 2024 | 14.12 | +0.14 |
Genedrive Plc | D6M | 30. avr 2024 | 0.03 | -15.07 |
Genetic Technologies Ltd. | DU8 | 30. avr 2024 | 0.06 | -0.87 |
Integrated Diagnostics Holdings Plc | 8I8 | 30. avr 2024 | 0.25 | -6.06 |
Leveljump Healthcare Corp. | 75J | 30. avr 2024 | 0.02 | -35.53 |
Lonza Group AG | LO3A | 30. avr 2024 | 53.50 | 0.00 |
Median Technologies | 4ZG | 30. avr 2024 | 2.71 | -8.28 |
Monash IVF Group Limited | MIS | 30. avr 2024 | 0.87 | 0.00 |
NanoRepro AG | NN6 | 30. avr 2024 | 1.78 | +2.29 |
Novacyt | NYZ | 30. avr 2024 | 0.82 | +0.37 |
Proteome Sciences plc | PI2 | 30. avr 2024 | 0.04 | 0.00 |
Renalytix AI PLC ORD GBP0.0025 Reg S Ordinary Shares Unite | 2O9 | 30. avr 2024 | 0.26 | +2.34 |
Selvita S.A. | 787 | 30. avr 2024 | 15.36 | +1.59 |
Shin Nippon Biomedical Laboratories | YB3 | 30. avr 2024 | 8.95 | +2.87 |
Siemens Healthineers AG | SHL1 | 30. avr 2024 | 26.00 | 0.00 |
Sysmex Corporation | 0YX | 30. avr 2024 | 14.70 | -6.96 |
Telo Genomics Corp | 3D0A | 30. avr 2024 | 0.09 | 0.00 |
Verici Dx Plc | 63V | 30. avr 2024 | 0.08 | 0.00 |
Voxel SA | 0NX | 30. avr 2024 | 21.00 | +1.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.